A Day Up For NovoCure Limited
Thu, Jan 05, 2023 at 07:02 PM
NovoCure Limited (NVCR:NASDAQ) shot up at $118.81, representing a gain of 68.5%. On Thu, Jan 05, 2023, NVCR:NASDAQ touched a New 2-Week High of $118.81. The stock appeared on our News Catalysts scanner on Thu, Jan 05, 2023 at 04:28 PM in the 'MISCELLANEOUS' category. From Thu, Dec 22, 2022, the stock recorded 62.50% Up Days and 66.67% Green Days
About NovoCure Limited (NVCR:NASDAQ)
NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors.
Top 10 Gainers:
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 199.5%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 160.2%
- Magic Empire Global Limited (MEGL:NASDAQ), 75.57%
- NovoCure Limited (NVCR:NASDAQ), 68.45%
- TIAN RUIXIANG Holdings Ltd (TIRX:NASDAQ), 58.54%
- Vyant Bio Inc. (VYNT:NASDAQ), 57.18%
- Jianzhi Education Technology Group Company Limited (JZ:NASDAQ), 47.06%
- Zai Lab Limited (ZLAB:NASDAQ), 41.8%
- Rockley Photonics Holdings Limited (RKLY:NYSE), 34.63%
- Argo Blockchain plc (ARBK:NASDAQ), 33.33%